Cargando…

Compatibility of fosfomycin with different commercial peritoneal dialysis solutions

For treatment of peritoneal dialysis-related peritonitis, intraperitoneal administration of antibiotics remains the preferable route. For home-based therapy, patients are commonly supplied with peritoneal dialysis fluids already containing antimicrobial agents. The present study set out to investiga...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kussmann, M., Baumann, A., Hauer, S., Pichler, P., Zeitlinger, M., Wiesholzer, M., Burgmann, H., Poeppl, W., Reznicek, G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653715/ https://www.ncbi.nlm.nih.gov/pubmed/28685187 http://dx.doi.org/10.1007/s10096-017-3051-3

Ejemplares similares

Compatibility of ciprofloxacin with commercial peritoneal dialysis solutions
por: Kussmann, Manuel, et al.
Publicado: (2019)

Influence of different peritoneal dialysis fluids on the in vitro activity of fosfomycin against Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa
por: Kussmann, Manuel, et al.
Publicado: (2018)

Compatibility of aztreonam in four commercial peritoneal dialysis fluids
por: Tobudic, Selma, et al.
Publicado: (2020)

Stability and compatibility of antibiotics in peritoneal dialysis solutions
por: So, Simon Wai Yin, et al.
Publicado: (2022)

Culture-directed antibiotics in peritoneal dialysis solutions: a systematic review focused on stability and compatibility
por: Ling, Chau Wei, et al.
Publicado: (2023)

Synergistic Effect of Cefazolin Plus Fosfomycin Against Staphylococcus aureus in vitro and in vivo in an Experimental Galleria mellonella Model
por: Kussmann, Manuel, et al.
Publicado: (2021)

Peritoneal dialysis-related peritonitis: challenges and solutions
por: Salzer, William L
Publicado: (2018)

Dalbavancin for treatment of implant-related methicillin-resistant Staphylococcus aureus osteomyelitis in an experimental rat model
por: Kussmann, Manuel, et al.
Publicado: (2018)

Elimination of fosfomycin during dialysis with the Genius system in septic patients
por: Dimski, T., et al.
Publicado: (2021)

Peritoneal Fluid Transport rather than Peritoneal Solute Transport Associates with Dialysis Vintage and Age of Peritoneal Dialysis Patients
por: Waniewski, Jacek, et al.
Publicado: (2016)

Fosfomycin Susceptibility Testing Using Commercial Agar Dilution Test
por: Croughs, Peter D., et al.
Publicado: (2022)

Treatment with Oral Active Vitamin D Is Associated with Decreased Risk of Peritonitis and Improved Survival in Patients on Peritoneal Dialysis
por: Kerschbaum, Julia, et al.
Publicado: (2013)

Different treatment options in peritoneal dialysis
por: van den Berg, Roy, et al.
Publicado: (2008)

Differences in peritoneal response after exposure to low-GDP bicarbonate/lactate-buffered dialysis solution compared to conventional dialysis solution in a uremic mouse model
por: Vila Cuenca, M., et al.
Publicado: (2018)

Increased peritoneal permeability at peritoneal dialysis initiation is a potential cardiovascular risk in patients using biocompatible peritoneal dialysis solution
por: Hamasaki, Yoshifumi, et al.
Publicado: (2014)

Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients
por: Cho, Yeoungjee, et al.
Publicado: (2014)

Different patterns of inflammatory and angiogenic factors are associated with peritoneal small solute transport and peritoneal protein clearance in peritoneal dialysis patients
por: Shi, Yuanyuan, et al.
Publicado: (2018)

Challenges and possible solutions to peritoneal dialysis use in Nigeria
por: Ajayi, Samuel, et al.
Publicado: (2020)

Is Assisted Peritoneal Dialysis a Solution for Northern Manitoba?
por: Lavoie, Josée G., et al.
Publicado: (2019)

Glycine improves peritoneal vasoreactivity to dialysis solutions in the elderly
por: Zakaria, El Rasheid, et al.
Publicado: (2019)

Peritoneal Protein Losses and Cytokine Generation in Automated Peritoneal Dialysis with Combined Amino Acids and Glucose Solutions
por: Tjiong, H. L., et al.
Publicado: (2007)

Unfavorable Effects of Peritoneal Dialysis Solutions on the Peritoneal Membrane: The Role of Oxidative Stress
por: Roumeliotis, Stefanos, et al.
Publicado: (2020)

Pharmacokinetics of the P-gp Inhibitor Tariquidar in Rats After Intravenous, Oral, and Intraperitoneal Administration
por: Matzneller, Peter, et al.
Publicado: (2018)

Survival of Peritoneal Membrane Function on Biocompatible Dialysis Solutions in a Peritoneal Dialysis Cohort Assessed by a Novel Test
por: Balafa, Olga, et al.
Publicado: (2021)

Availability of assisted peritoneal dialysis in Europe: call for increased and equal access
por: Brown, Edwina A, et al.
Publicado: (2022)

Bioincompatible Impact of Different Peritoneal Dialysis Fluid Components and Therapeutic Interventions as Tested in a Rat Peritoneal Dialysis Model
por: Stavenuiter, Andrea W. D., et al.
Publicado: (2011)

The calcium concentration of peritoneal dialysis solution modifies levels of key mediators of peritoneal fibrosis
por: Miao, Chusheng, et al.
Publicado: (2020)

Resolution of severe eosinophilic peritonitis in a patient on continuous ambulatory peritoneal dialysis by changing from Dianeal peritoneal dialysis solution to Stay-Safe Balance solution: a case report
por: Chan, Zi, et al.
Publicado: (2022)

The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients
por: Ye, Hongjian, et al.
Publicado: (2017)

Peritoneal macrophage heterogeneity is associated with different peritoneal dialysis outcomes
por: Liao, Chia-Te, et al.
Publicado: (2017)

Use of Commercially Available Multiplex Polymerase Chain Reaction in Detection of Organism in Culture Negative Peritonitis in Peritoneal Dialysis
por: Veerappan, I., et al.
Publicado: (2019)

Psychiatrist and Peritoneal Dialysis
por: Klarić, D., et al.
Publicado: (2022)

Bimodal Solutions or Twice-Daily Icodextrin to Enhance Ultrafiltration in Peritoneal Dialysis Patients
por: Dousdampanis, Periklis, et al.
Publicado: (2013)

Transcriptome analysis of signaling pathways of human peritoneal mesothelial cells in response to different osmotic agents in a peritoneal dialysis solution
por: Liu, Bin, et al.
Publicado: (2019)

Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis
por: Alvarez Nadal, Marta, et al.
Publicado: (2020)

Peritoneal Dialysis
por: Pyper, R. A.
Publicado: (1948)

Peritoneal Dialysis
por: Taskapan, Hulya, et al.
Publicado: (2011)

A New Peritoneal Dialysis Solution Containing L-Carnitine and Xylitol for Patients on Continuous Ambulatory Peritoneal Dialysis: First Clinical Experience
por: Rago, Carmela, et al.
Publicado: (2021)

Synergistic Effects from Combination of Cryptotanshinone and Fosfomycin Against Fosfomycin-Susceptible and Fosfomycin-Resistant Staphylococcus aureus
por: Ruan, Zijing, et al.
Publicado: (2020)

Fosfomycin and breastfeeding
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ihrsuukl1p4bhu6vhitr25f8as